Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 28;10(13):2855.
doi: 10.3390/jcm10132855.

Gender Differences in the Medical Treatment of Peripheral Artery Disease

Damien Lanéelle  1   2 , Gabriella Sauvet  3 , Jérôme Guillaumat  1 , Jean Eudes Trihan  4 , Guillaume Mahé  5   6
Affiliations

Gender Differences in the Medical Treatment of Peripheral Artery Disease

Damien Lanéelle et al. J Clin Med. .

Abstract

Background/objectives: Peripheral arterial disease is a frequent and severe disease with high cardiovascular morbidity and mortality. However, female patients appear to be undertreated.

Objectives: The primary goal was to compare the prescription of optimal medical treatment (OMT) of peripheral arterial disease between women and men in primary health care.

Material and methods: An observational retrospective study was based on the data collected from general practitioners (GP) office in Brittany.

Results: The study included 100 patients, aged 71 ± 10 years old, with 24% of women. Compared to men, women received the OMT less frequently (29.2% vs. 53.9%, p = 0.038), especially after 75 years old. Antiplatelet therapy was largely prescribed (100%), statins less frequently (70.8% women vs. 85.5% men), and prescription of renin-angiotensin-aldosterone system inhibitors was still not optimal in the two genders (41.7% women vs. 61.9% men). Active smoking is important for both women and men (33% and 30% respectively).

Conclusion: Optimal medical treatment of peripheral artery disease is insufficiently prescribed, especially in women in this region of France.

Keywords: gender differences; optimal medical treatment; peripheral arterial disease.

PubMed Disclaimer

Conflict of interest statement

Guillaume Mahé declares that he has no conflict of interest. Damien Lanéelle declares that he has no conflict of interest. Jean-Eudes Trihan declares that he has no conflict of interest. Gabriella Sauvet declares that he has no conflict of interest. Jérôme Guillaumat declares that he has no conflict of interest.

References

    1. Song P., Rudan D., Zhu Y., Fowkes F.J., Rahimi K., Fowkes F., Rudan I. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: An updated systematic review and analysis. Lancet Glob. Health. 2019;7:e1020–e1030. doi: 10.1016/S2214-109X(19)30255-4. - DOI - PubMed
    1. Aboyans V., Ricco J.B., Bartelink M.L., Björck M., Brodmann M., Cohner T., Collet J.P., Czerny M., De Carlo M., Debus S., et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases. Eur Heart J. 2018;39:763–816. doi: 10.1093/eurheartj/ehx095. - DOI - PubMed
    1. Gerhard-Herman M.D., Gornik H.L., Barrett C., Barshes N.R., Corriere M.A., Drachman D.E., Fleisher L.A., Fowkes F.G.R., Hamburg N.M., Kinlay S., et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2017;69:1465–1508. doi: 10.1016/j.jacc.2016.11.008. - DOI - PubMed
    1. Frank U., Nikol S., Belch J., Boc V., Brodmann M., Carpentier P.H., Chraim A., Canning C., Dimakakos E., Gottsäter A., et al. ESVM Guideline on peripheral arterial disease. Vasa. 2019;48(Suppl. S102):1–79. doi: 10.1024/0301-1526/a000834. - DOI - PubMed
    1. Mahé G., Boge G., Bura-Rivière A., Chakfé N., Constans J., Goueffic Y., Lacroix P., Le Hello C., Pernod G., Perez-Martin A., et al. Disparities Between International Guidelines (AHA/ESC/ESVS/ESVM/SVS) Concerning Lower Extremity Arterial Disease: Consensus of the French Society of Vascular Medicine (SFMV) and the French Society for Vascular and Endovascular Surgery (SCVE) Ann. Vasc. Surg. 2021;72:1–56. doi: 10.1016/j.avsg.2020.11.011. - DOI - PubMed

LinkOut - more resources